These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16109476)

  • 41. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
    Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
    Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.
    Xu B; Tong N; Chen SQ; Hua LX; Wang ZJ; Zhang ZD; Chen M
    BMC Cancer; 2011 Feb; 11():84. PubMed ID: 21349172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer.
    Marmé F; Hielscher T; Hug S; Bondong S; Zeillinger R; Castillo-Tong DC; Sehouli J; Braicu I; Vergote I; Isabella C; Mahner S; Ferschke I; Rom J; Sohn C; Schneeweiss A; Altevogt P
    Int J Cancer; 2012 Aug; 131(4):E586-91. PubMed ID: 22034009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition.
    Ye Y; Li J; Jiang D; Li J; Xiao C; Li Y; Han C; Zhao C
    Cancer Res Treat; 2020 Oct; 52(4):1162-1177. PubMed ID: 32599983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression.
    Zhao X; Xu F; Dominguez NP; Xiong Y; Xiong Z; Peng H; Shay C; Teng Y
    Mol Carcinog; 2018 Nov; 57(11):1616-1625. PubMed ID: 30074276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival.
    Tiong KH; Tan BS; Choo HL; Chung FF; Hii LW; Tan SH; Khor NT; Wong SF; See SJ; Tan YF; Rosli R; Cheong SK; Leong CO
    Oncotarget; 2016 Sep; 7(36):57633-57650. PubMed ID: 27192118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Polymorphism in the FGFR4 Gene Is Associated With Risk of Neuroblastoma and Altered Receptor Degradation.
    Whittle SB; Reyes S; Du M; Gireud M; Zhang L; Woodfield SE; Ittmann M; Scheurer ME; Bean AJ; Zage PE
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):131-8. PubMed ID: 26840079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FGFR4 phosphorylates MST1 to confer breast cancer cells resistance to MST1/2-dependent apoptosis.
    Turunen SP; von Nandelstadh P; Öhman T; Gucciardo E; Seashore-Ludlow B; Martins B; Rantanen V; Li H; Höpfner K; Östling P; Varjosalo M; Lehti K
    Cell Death Differ; 2019 Dec; 26(12):2577-2593. PubMed ID: 30903103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Re-evaluating the FGFR4 (G388R) germline mutation in different cancers in Pakistani population.
    Mansoor Q; Fayyaz S; Farooqi AA; Bhatti S; Ismail M
    J Exp Ther Oncol; 2013; 10(3):215-7. PubMed ID: 24416997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer.
    Wei W; You Z; Sun S; Wang Y; Zhang X; Pang D; Jiang Y
    Mol Carcinog; 2018 Aug; 57(8):988-996. PubMed ID: 29603419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FGFR4 and its novel splice form in myogenic cells: Interplay of glycosylation and tyrosine phosphorylation.
    Kwiatkowski BA; Kirillova I; Richard RE; Israeli D; Yablonka-Reuveni Z
    J Cell Physiol; 2008 Jun; 215(3):803-17. PubMed ID: 18186042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis.
    Huang X; Yang C; Jin C; Luo Y; Wang F; McKeehan WL
    Mol Carcinog; 2009 Jun; 48(6):553-62. PubMed ID: 19009564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FGFR4: A promising therapeutic target for breast cancer and other solid tumors.
    Levine KM; Ding K; Chen L; Oesterreich S
    Pharmacol Ther; 2020 Oct; 214():107590. PubMed ID: 32492514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.
    Frullanti E; Berking C; Harbeck N; Jézéquel P; Haugen A; Mawrin C; Parise O; Sasaki H; Tsuchiya N; Dragani TA
    Eur J Cancer Prev; 2011 Jul; 20(4):340-7. PubMed ID: 21412156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors.
    Cros J; Moati E; Raffenne J; Hentic O; Svrcek M; de Mestier L; Sbidian E; Guedj N; Bedossa P; Paradis V; Sauvanet A; Panis Y; Ruszniewski P; Couvelard A; Hammel P
    Neuroendocrinology; 2016; 103(5):495-9. PubMed ID: 26335532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease.
    Garcia-Recio S; Thennavan A; East MP; Parker JS; Cejalvo JM; Garay JP; Hollern DP; He X; Mott KR; Galván P; Fan C; Selitsky SR; Coffey AR; Marron D; Brasó-Maristany F; Burgués O; Albanell J; Rojo F; Lluch A; de Dueñas EM; Rosen JM; Johnson GL; Carey LA; Prat A; Perou CM
    J Clin Invest; 2020 Sep; 130(9):4871-4887. PubMed ID: 32573490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.
    Xiong SW; Ma J; Feng F; Fu W; Shu SR; Ma T; Wu C; Liu GC; Zhu J
    Oncotarget; 2017 Apr; 8(15):25300-25309. PubMed ID: 28445975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FGFR4 role in epithelial-mesenchymal transition and its therapeutic value in colorectal cancer.
    Peláez-García A; Barderas R; Torres S; Hernández-Varas P; Teixidó J; Bonilla F; de Herreros AG; Casal JI
    PLoS One; 2013; 8(5):e63695. PubMed ID: 23696849
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Photoactivation approaches reveal a role for Rab11 in FGFR4 recycling and signalling.
    Haugsten EM; Brech A; Liestøl K; Norman JC; Wesche J
    Traffic; 2014 Jun; 15(6):665-83. PubMed ID: 24589086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy.
    Shim HJ; Shin MH; Kim HN; Kim JH; Hwang JE; Bae WK; Chung IJ; Cho SH
    Cancer Res Treat; 2016 Jan; 48(1):71-9. PubMed ID: 25989802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.